A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Recruiting now

Conditions studied: Type 2 Diabetes

In brief

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Key facts

Study ID: NCT07606066
Run by: AstraZeneca
People needed: 2150
Starts: 2026-05-06
Expected to finish: 2027-03-31
Last updated by the study team: 2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Participants must be ≥ 18 years of age at the time of signing the ICF.
Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World
Health Organization or local diagnostic standards, inadequately managed with:
Lifestyle management alone, AND/OR
A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.
Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.
Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.

You may not qualify if…

Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol).
Diagnosed with Type 1 diabetes mellitus.
Known pregnancy at the time of visit or having the intention to become pregnant.

Where it is running

Research Site — Potomac, Maryland, United States (enrolling)
Research Site — Decatur, Georgia, United States (enrolling)
Research Site — Budapest, Hungary (enrolling)
Research Site — Ocoee, Florida, United States (enrolling)
Research Site — Budapest, Hungary (enrolling)
Research Site — Lincoln, California, United States (enrolling)
Research Site — Bialystok, Podlaskie Voivodeship, Poland (enrolling)
Research Site — Campinas, S O Paulo, Brazil
Research Site — El Dorado, Kansas, United States
Research Site — Lake City, Florida, United States
Research Site — Natal, Rio Grande do Norte, Brazil
Research Site — Porto Alegre, Rio Grande do Sul, Brazil
Research Site — Curitiba, Paraná, Brazil
Research Site — São José dos Campos, S O Paulo, Brazil
Research Site — Rio de Janeiro, Brazil
Research Site — Fortaleza, Ceará, Brazil
Research Site — Brasília, Brazil
Research Site — Barretos, Brazil
Research Site — São Paulo, São Paulo, Brazil
Research Site — Budapest, HU, Hungary
Research Site — Budapest, HU, Hungary
Research Site — Debrecen, HU, Hungary
Research Site — Szeged, HU, Hungary
Research Site — São Paulo, São Paulo, Brazil
Research Site — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.